216 related articles for article (PubMed ID: 37864566)
1. Research Status of Systemic Adjuvant Therapy for Early Breast Cancer.
Hu W; Xu D; Li N
Cancer Control; 2023; 30():10732748231209193. PubMed ID: 37864566
[TBL] [Abstract][Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
3. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
4. The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.
Sammons S; Sedrak MS; Kimmick GG
Drugs Aging; 2020 May; 37(5):331-348. PubMed ID: 32100240
[TBL] [Abstract][Full Text] [Related]
5. Progress in adjuvant chemotherapy for breast cancer: an overview.
Anampa J; Makower D; Sparano JA
BMC Med; 2015 Aug; 13():195. PubMed ID: 26278220
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
7. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?
Leonard CE; Wood ME; Zhen B; Rankin J; Waitz DA; Norton L; Howell K; Sedlacek S
J Clin Oncol; 1995 Dec; 13(12):2906-15. PubMed ID: 8523054
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
9. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
Anderson SJ; Wapnir I; Dignam JJ; Fisher B; Mamounas EP; Jeong JH; Geyer CE; Wickerham DL; Costantino JP; Wolmark N
J Clin Oncol; 2009 May; 27(15):2466-73. PubMed ID: 19349544
[TBL] [Abstract][Full Text] [Related]
10. Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy.
Synnestvedt M; Borgen E; Russnes HG; Kumar NT; Schlichting E; Giercksky KE; Kåresen R; Nesland JM; Naume B
Acta Oncol; 2013 Jan; 52(1):91-101. PubMed ID: 22934555
[TBL] [Abstract][Full Text] [Related]
11. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
12. Reducing the risk of late recurrence in hormone-responsive breast cancer.
Cufer T
Ann Oncol; 2007 Sep; 18 Suppl 8():viii18-25. PubMed ID: 17890210
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant drug therapy for operable breast cancer.
Hudis CA; Norton L
Semin Oncol; 1996 Aug; 23(4):475-93. PubMed ID: 8757274
[TBL] [Abstract][Full Text] [Related]
14. [Current status of treatment for early-stage invasive breast cancer].
Kásler M; Polgár C; Fodor J
Orv Hetil; 2009 May; 150(22):1013-21. PubMed ID: 19465349
[TBL] [Abstract][Full Text] [Related]
15. Overview of adjuvant systemic therapy in early stage breast cancer.
Newman LA; Singletary SE
Surg Clin North Am; 2007 Apr; 87(2):499-509, xi. PubMed ID: 17498540
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
Overgaard M; Jensen MB; Overgaard J; Hansen PS; Rose C; Andersson M; Kamby C; Kjaer M; Gadeberg CC; Rasmussen BB; Blichert-Toft M; Mouridsen HT
Lancet; 1999 May; 353(9165):1641-8. PubMed ID: 10335782
[TBL] [Abstract][Full Text] [Related]
17. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.
Aebi S; Gelber S; Anderson SJ; Láng I; Robidoux A; Martín M; Nortier JW; Paterson AH; Rimawi MF; Cañada JM; Thürlimann B; Murray E; Mamounas EP; Geyer CE; Price KN; Coates AS; Gelber RD; Rastogi P; Wolmark N; Wapnir IL;
Lancet Oncol; 2014 Feb; 15(2):156-63. PubMed ID: 24439313
[TBL] [Abstract][Full Text] [Related]
19. Current Strategies for the Management of Locoregional Breast Cancer Recurrence.
Wapnir IL; Khan A
Oncology (Williston Park); 2019 Jan; 33(1):19-25. PubMed ID: 30731014
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
